Broadfin Capital
ISEE

Broadfin Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Broadfin Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-410,000
Closed -$18.9M – 71
2016
Q3 		$18.9M Buy
410,000
+232,600
+131% +$13.1M 1.7% 17
2016
Q2 		$9.05M Buy
+177,400
New +$8.81M 0.88% 30
2014
Q1 		– Sell
-150,000
Closed -$4.85M – 89
2013
Q4 		$4.85M Buy
+150,000
New +$4.45M 0.64% 40

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Tourbillon Capital Partners
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Bogle Investment Management
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Broadfin Capital's ISEE Position: Q4 2016 in Review

Broadfin Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 410,000 shares — an estimated $18.9M sold.

Broadfin Capital first reported a position in ISEE in Q4 2013 and held it in 3 quarters. The position peaked at $18.9M in Q3 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Broadfin Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Broadfin Capital sold 410,000 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $18.9M.
  • Broadfin Capital first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
  • Broadfin Capital's IVERIC bio, Inc. Common Stock position peaked at $18.9M in Q3 2016.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Broadfin Capital's 13F filing for Q4 2016, filed 14 Feb 2017.